California-based Allez Health, formerly Zense-Life Inc., announced it secured $60 million in Series A+ financing. The round was led by strategic investor Osang Healthcare Co., Ltd., with participation from existing investors.
WHAT IT DOES
Allez Health is…
What You Should Know:
– Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligence…
Continue Reading
What You Should Know:
– Senseonics Holdings, Inc., a provider of long-term implantable continuous glucose monitoring (CGM) systems, today announced a strategic partnership with Rimidi. Rimidi offers a comprehensive clinical management platform designed to improve…
Continue Reading
Biosensor Platform Leverages Silicon Semiconductor Manufacturing for Scale
Technology Designed to Provide a Better View of Metabolic Health by Combining Glucose Information with Context Around Activities of Daily Living in One Device
$58 Million in Funding…
We evaluated the effectiveness of a mobile health (mHealth) intervention for diabetic kidney disease patients by conducting a 12-month randomized controlled trial among 126 type 2 diabetes mellitus patients with moderately increased albuminuria (urinary…
Continue Reading
What You Should Know:
– MD Revolution, known for its remote care management solutions, collaborates with Dexcom to integrate cutting-edge continuous glucose monitoring systems into its platform.
– Dexcom, a global leader in real-time continuous glucose monitoring, serves…
Continue Reading
Labour has announced a new partnership with Virgin Media O2, to ensure every child with type 1 diabetes can benefit from the latest technology. Labour also said it will digitise the red book given to…
Continue Reading
This week, San Diego-based company Biolinq raked in $58 million in a funding round led by Alpha Wave Ventures, bringing its total funding to date to $178 million.
The company, founded in 2012, is developing…
Continue Reading
What You Should Know: – Biolinq, a provider of precision wearable biosensors for metabolic health secures $58M led by Alpha Wave Ventures. The round will include participation from Niterra’s corporate venture capital fund jointly…
Continue Reading
California-based Biolinq, a health technology company developing precision multi-analyte wearable biosensors for metabolic health, announced it scored $58 million in financing.Alpha Wave Ventures led the round, with participation from Niterra’s corporate venture capital fund,…
Continue Reading
